January 4, 2008  
IBL GESELLSCHAFT: Files for Insolvency at Hamburg Court

Hamburg-based IBL Gesellschaft fuer Immunchemie und
Immunbiologie mbH, a 100% subsidiary of november AG (ISIN
DE000A0S9N72), has filed for insolvency on Dec. 20, 2007, with
the local court of Hamburg.  The company cited illiquidity and
over-indebtedness on its balance sheet.

This is because the ongoing negotiations with different banks
relating to different loans could not be concluded in time
before the expiry of the insolvency deadline.



   
   
   
   
   
   

 THE TROUBLED COMPANY REPORTER - EUROPE
 Today's Top Stories have been selected from the Troubled Company Reporter -  Europe. To receive the Full TCR-EUR please CLICK HERE.